Table II.
Recombinant Der 23 |
PreS-2XP4P5 |
|||||
---|---|---|---|---|---|---|
Patient | Preimmune Serum | Antiserum | % of Inhibition | Preimmune Serum | Antiserum | % of Inhibition |
1 | 0.81 | 0.13 | 83.63 | 0.79 | 0.20 | 75.10 |
2 | 0.23 | 0.05 | 76.86 | 0.26 | 0.07 | 71.03 |
3 | 0.30 | 0.09 | 70.80 | 0.28 | 0.11 | 59.92 |
4 | 1.72 | 0.11 | 93.84 | 1.55 | 0.19 | 87.89 |
6 | 0.30 | 0.11 | 62.15 | 0.31 | 0.12 | 60.88 |
10 | 0.33 | 0.04 | 86.90 | 0.34 | 0.06 | 81.07 |
11 | 0.69 | 0.27 | 60.89 | 0.86 | 0.34 | 60.09 |
13 | 2.09 | 0.14 | 93.49 | 2.06 | 0.46 | 77.64 |
14 | 0.88 | 0.12 | 85.97 | 0.85 | 0.22 | 74.64 |
17 | 0.39 | 0.05 | 86.34 | 0.42 | 0.09 | 79.14 |
18 | 0.69 | 0.09 | 86.58 | 0.64 | 0.08 | 86.99 |
19 | 0.83 | 0.11 | 86.46 | 0.86 | 0.31 | 63.47 |
20 | 0.34 | 0.06 | 83.12 | 0.34 | 0.07 | 78.46 |
21 | 0.20 | 0.07 | 67.21 | 0.22 | 0.08 | 65.35 |
22 | 0.57 | 0.18 | 67.92 | 0.62 | 0.26 | 57.60 |
23 | 0.98 | 0.20 | 79.65 | 0.92 | 0.33 | 64.09 |
24 | 3.23 | 0.29 | 90.88 | 3.22 | 1.02 | 68.23 |
25 | 0.65 | 0.22 | 65.42 | 0.68 | 0.32 | 52.28 |
26 | 2.12 | 0.24 | 88.72 | 2.02 | 0.61 | 69.91 |
28 | 0.86 | 0.08 | 90.12 | 0.81 | 0.24 | 70.25 |
29 | 0.30 | 0.06 | 78.52 | 0.31 | 0.12 | 61.17 |
32 | 1.33 | 0.13 | 90.57 | 1.37 | 0.21 | 84.48 |
34 | 0.42 | 0.13 | 69.81 | 0.42 | 0.17 | 58.58 |
39 | 2.16 | 0.16 | 92.40 | 2.19 | 0.62 | 71.83 |
40 | 2.99 | 0.29 | 90.16 | 3.15 | 1.22 | 61.36 |
57 | 2.00 | 0.30 | 85.12 | 1.89 | 0.88 | 53.37 |
64 | 0.70 | 0.07 | 90.32 | 0.70 | 0.08 | 88.54 |
65 | 3.09 | 0.29 | 90.49 | 3.09 | 0.64 | 79.18 |
Mean | 1.11 | 0.15 | 81.94 | 1.11 | 0.33 | 70.09 |
The optical densities, corresponding to the amount of bound Abs, are shown after preincubation with the preimmune sera or antiserum.